Cargando…

Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis

BACKGROUND: Ophthalmic viscosurgical devices (OVDs) are commonly used during cataract surgery to protect the corneal endothelium. A systematic literature review and meta-analysis were conducted to assess the clinical evidence of OVDs composed of chondroitin sulfate-hyaluronic acid (CS-HA) versus oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Chia-Wen, Cheng, Hang, Ghafouri, Rana, Ferko, Nicole C, Ayres, Brandon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378560/
https://www.ncbi.nlm.nih.gov/pubmed/37521151
http://dx.doi.org/10.2147/OPTH.S419863
_version_ 1785079797600223232
author Hsiao, Chia-Wen
Cheng, Hang
Ghafouri, Rana
Ferko, Nicole C
Ayres, Brandon D
author_facet Hsiao, Chia-Wen
Cheng, Hang
Ghafouri, Rana
Ferko, Nicole C
Ayres, Brandon D
author_sort Hsiao, Chia-Wen
collection PubMed
description BACKGROUND: Ophthalmic viscosurgical devices (OVDs) are commonly used during cataract surgery to protect the corneal endothelium. A systematic literature review and meta-analysis were conducted to assess the clinical evidence of OVDs composed of chondroitin sulfate-hyaluronic acid (CS-HA) versus other OVDs in maintaining endothelial cell density (ECD) and corneal thickness (CT). METHODS: MEDLINE and EMBASE databases were searched from 2000 to 2020. Randomized controlled trials (RCTs, N ≥ 20 per group) comparing an OVD containing CS-HA (ie, VISCOAT(®), DuoVisc(®) or DisCoVisc(®)) to any other OVD were included. The identified comparators were limited to the OVDs found in the literature, which included those composed of HA-only or hydroxypropyl methylcellulose (HPMC). Outcomes of focus included changes in ECD (baseline to 3 months) and CT (baseline to 24 hours). Meta-analyses were performed using R software, to assess mean differences (MD) in ECD and CT change between CS-HA OVDs and HA-only or HPMC OVDs. RESULTS: A total of 966 abstracts were screened, and data were extracted from 12 RCTs. Meta-analyses using a random-effects model revealed significantly lower percent (%) decrease in ECD for CS-HA OVDs compared to both HA-only (MD: −4.10%; 95% CI: −5.81 to −2.40; p < 0.0001; 9 studies) and HPMC (MD: −6.47%; 95% CI: −10.41 to −2.52; p = 0.001; 2 studies) products. Similarly, % CT increase was significantly lower with CS-HA than with HA-only OVDs (MD: −3.22%; 95% CI: −6.24% to −0.20%; p = 0.04; 4 studies). However, there were no significant differences when comparing % CT change between CS-HA and HPMC OVDs (MD: 2.65%; 95% CI: −0.43% to 0.95%; p = 0.4; 2 studies). CONCLUSION: CS-HA OVDs lead to less postoperative loss of endothelial cells and may better protect corneal endothelium during cataract surgery, relative to other OVDs. Future randomized studies may be needed to solidify these findings.
format Online
Article
Text
id pubmed-10378560
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103785602023-07-29 Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis Hsiao, Chia-Wen Cheng, Hang Ghafouri, Rana Ferko, Nicole C Ayres, Brandon D Clin Ophthalmol Review BACKGROUND: Ophthalmic viscosurgical devices (OVDs) are commonly used during cataract surgery to protect the corneal endothelium. A systematic literature review and meta-analysis were conducted to assess the clinical evidence of OVDs composed of chondroitin sulfate-hyaluronic acid (CS-HA) versus other OVDs in maintaining endothelial cell density (ECD) and corneal thickness (CT). METHODS: MEDLINE and EMBASE databases were searched from 2000 to 2020. Randomized controlled trials (RCTs, N ≥ 20 per group) comparing an OVD containing CS-HA (ie, VISCOAT(®), DuoVisc(®) or DisCoVisc(®)) to any other OVD were included. The identified comparators were limited to the OVDs found in the literature, which included those composed of HA-only or hydroxypropyl methylcellulose (HPMC). Outcomes of focus included changes in ECD (baseline to 3 months) and CT (baseline to 24 hours). Meta-analyses were performed using R software, to assess mean differences (MD) in ECD and CT change between CS-HA OVDs and HA-only or HPMC OVDs. RESULTS: A total of 966 abstracts were screened, and data were extracted from 12 RCTs. Meta-analyses using a random-effects model revealed significantly lower percent (%) decrease in ECD for CS-HA OVDs compared to both HA-only (MD: −4.10%; 95% CI: −5.81 to −2.40; p < 0.0001; 9 studies) and HPMC (MD: −6.47%; 95% CI: −10.41 to −2.52; p = 0.001; 2 studies) products. Similarly, % CT increase was significantly lower with CS-HA than with HA-only OVDs (MD: −3.22%; 95% CI: −6.24% to −0.20%; p = 0.04; 4 studies). However, there were no significant differences when comparing % CT change between CS-HA and HPMC OVDs (MD: 2.65%; 95% CI: −0.43% to 0.95%; p = 0.4; 2 studies). CONCLUSION: CS-HA OVDs lead to less postoperative loss of endothelial cells and may better protect corneal endothelium during cataract surgery, relative to other OVDs. Future randomized studies may be needed to solidify these findings. Dove 2023-07-24 /pmc/articles/PMC10378560/ /pubmed/37521151 http://dx.doi.org/10.2147/OPTH.S419863 Text en © 2023 Hsiao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Hsiao, Chia-Wen
Cheng, Hang
Ghafouri, Rana
Ferko, Nicole C
Ayres, Brandon D
Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis
title Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis
title_full Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis
title_fullStr Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis
title_full_unstemmed Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis
title_short Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis
title_sort corneal outcomes following cataract surgery using ophthalmic viscosurgical devices composed of chondroitin sulfate-hyaluronic acid: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378560/
https://www.ncbi.nlm.nih.gov/pubmed/37521151
http://dx.doi.org/10.2147/OPTH.S419863
work_keys_str_mv AT hsiaochiawen cornealoutcomesfollowingcataractsurgeryusingophthalmicviscosurgicaldevicescomposedofchondroitinsulfatehyaluronicacidasystematicreviewandmetaanalysis
AT chenghang cornealoutcomesfollowingcataractsurgeryusingophthalmicviscosurgicaldevicescomposedofchondroitinsulfatehyaluronicacidasystematicreviewandmetaanalysis
AT ghafourirana cornealoutcomesfollowingcataractsurgeryusingophthalmicviscosurgicaldevicescomposedofchondroitinsulfatehyaluronicacidasystematicreviewandmetaanalysis
AT ferkonicolec cornealoutcomesfollowingcataractsurgeryusingophthalmicviscosurgicaldevicescomposedofchondroitinsulfatehyaluronicacidasystematicreviewandmetaanalysis
AT ayresbrandond cornealoutcomesfollowingcataractsurgeryusingophthalmicviscosurgicaldevicescomposedofchondroitinsulfatehyaluronicacidasystematicreviewandmetaanalysis